helionbiotech.comContact us
About company
Restoration of inherited immune defect by replacement therapy with recombinant human mannan-binding lectin in MBL deficient preterm neonates for prevention of neonatal infections and sepsis.
AU
Unknown
Not verified company
Restoration of inherited immune defect by replacement therapy with recombinant human mannan-binding lectin in MBL deficient preterm neonates for prevention of neonatal infections and sepsis.
